Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Ocular Inflammation Treatment Market

Ocular Inflammation Treatment Market Share

  • Report ID: GMI8353
  • Published Date: Mar 2024
  • Report Format: PDF
 Download Free Sample

Ocular Inflammation Treatment Market Share

The ocular inflammation treatment industry is fragmented in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products with improved efficiency and cost-effectiveness is among a key market strategy for ocular inflammation treatment product manufacturers.
 

Ocular Inflammation Treatment Market Companies

Some of the eminent market participants operating in the ocular inflammation treatment industry include:

  • AbbVie Inc.
  • Alimera Sciences
  • Bausch Health Companies Inc.
  • EyePoint Pharmaceuticals, Inc.
  • Novartis AG
  • Ocular Therapeutix, Inc.
  • Pfizer Inc.
  • Santen Pharmaceutical Co., Ltd.
     
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of ocular inflammation treatment reached USD 7.5 billion in 2023 and is set to cross USD 11.4 billion by 2032, propelled by growing incidence of ocular inflammation and related complications coupled with rising expenditure on the R&D of novel treatments.

The corticosteroids segment was valued at over USD 1.9 billion in revenue in 2023, owing to the ability to suppress immune responses.

North America market recorded around USD 3 billion in revenue in 2023, attributed to robust healthcare infrastructure, extensive R&D initiatives, and a high prevalence of ocular inflammatory conditions.

AbbVie Inc., Alimera Sciences, Bausch Health Companies Inc., EyePoint Pharmaceuticals, Inc., Novartis AG, Ocular Therapeutix, Inc., Pfizer Inc., and Santen Pharmaceutical Co., Ltd.

Ocular Inflammation Treatment Market Scope

  • Ocular Inflammation Treatment Market Size
  • Ocular Inflammation Treatment Market Trends
  • Ocular Inflammation Treatment Market Analysis
  • Ocular Inflammation Treatment Market Share

    • Buy Now

    Premium Report Details

    • Base Year: 2023
    • Companies covered: 8
    • Tables & Figures: 307
    • Countries covered: 22
    • Pages: 180
     Download Free Sample
    ×
    Get a free sample of Ocular Inflammation Treatment Market
    Inquiry Before Buying
    Get special pricing options on this report
    Request Sectional Data
    Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours below

    Your personal details will remain secure and confidential.